Edwards Lifesciences Corp Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Edwards Lifesciences Corp quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Edwards Lifesciences Corp Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $92.8M, a 9.31% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $92.8M +$7.9M +9.31% Jun 30, 2024 10-Q 2024-07-31
Q1 2024 $98.4M +$9.9M +11.2% Mar 31, 2024 10-Q 2024-04-29
Q4 2023 $84.4M -$7.9M -8.56% Dec 31, 2023 10-Q 2024-07-31
Q3 2023 $90.9M +$3.2M +3.65% Sep 30, 2023 10-Q 2023-10-27
Q2 2023 $84.9M +$700K +0.83% Jun 30, 2023 10-Q 2023-07-28
Q1 2023 $88.5M -$1.6M -1.78% Mar 31, 2023 10-Q 2023-04-28
Q4 2022 $92.3M +$200K +0.22% Dec 31, 2022 10-K 2024-02-12
Q3 2022 $87.7M +$2.9M +3.42% Sep 30, 2022 10-Q 2022-10-28
Q2 2022 $84.2M -$400K -0.47% Jun 30, 2022 10-Q 2022-07-29
Q1 2022 $90.1M +$1.6M +1.81% Mar 31, 2022 10-Q 2022-04-28
Q4 2021 $92.1M -$2.1M -2.23% Dec 31, 2021 10-K 2023-02-13
Q3 2021 $84.8M -$4.7M -5.25% Sep 30, 2021 10-Q 2021-10-29
Q2 2021 $84.6M -$100K -0.12% Jun 30, 2021 10-Q 2021-07-30
Q1 2021 $88.5M +$13M +17.2% Mar 31, 2021 10-Q 2021-04-28
Q4 2020 $94.2M +$14.1M +17.6% Dec 31, 2020 10-K 2022-02-14
Q3 2020 $89.5M +$16.2M +22.1% Sep 30, 2020 10-Q 2020-10-26
Q2 2020 $84.7M +$13.5M +19% Jun 30, 2020 10-Q 2020-07-27
Q1 2020 $75.5M +$5.6M +8.01% Mar 31, 2020 10-Q 2020-04-28
Q4 2019 $80.1M Dec 31, 2019 10-K 2021-02-12
Q3 2019 $73.3M Sep 30, 2019 10-Q 2019-10-25
Q2 2019 $71.2M Jun 30, 2019 10-Q 2019-07-26
Q1 2019 $69.9M Mar 31, 2019 10-Q 2019-04-26
* An asterisk sign (*) next to the value indicates that the value is likely invalid.